In-Space Drug Development Program Expands

New Redwire PIL-BOX Technology and Cancer-Detection Experiment Launched to ISS

Apr 24, 2025

∙ Paid

A new drug development technology and a cancer-detection experiment has been launched to the International Space Station (ISS) as Redwire scales its in-space pharmaceutical drug development program based on the success of its PIL-BOX platform.

“Gold nanospheres could lead to early testing and diagnosis of cancer and other diseases, targeted drug delivery…

Continue reading this post for free, courtesy of Mike Turner.

Or purchase a paid subscription.